Anika Therapeutics share price logo

Anika Therapeutics

NASDAQ: ANIK

Small Cap

$20.81

-0.22

(-1.05%)

as on

Anika Therapeutics Stock Performance

as on September 19, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $20.59
    $21.05
    downward going graph

    1.06%

    Downside

    1.15%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $8.67
    $22.88
    downward going graph

    58.33%

    Downside

    9.95%

    Upside

    downward going graph

Anika Therapeutics share price movements today

Previous Close
$21.03
Open
$21.04
Volume
147.0K
Market Cap
$281.4M
Day's Low - High
$20.59 - $21.05
52 Week Low - High
$8.67 - $22.88

Anika Therapeutics Historical Returns

1 Month Return
-1.08 %
3 Month Return
+ 45.84 %
1 Year Return
+ 136.29 %
3 Year Return
+ 18.55 %
5 Year Return
-47 %

Anika Therapeutics Stock Fundamentals & Key Indicators

Check Anika Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$281.4M

EPS (TTM)

-0.2695

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-78.03

Industry PE ratio

2.29

PEG Ratio

-0.273724846853225

EBITDA

2.7M

Revenue (TTM)

120.7M

Profit Margin

62.16%

Return On Equity TTM

-2.70%

Anika Therapeutics Stock Valuation

Track how Anika Therapeutics P/E has moved over time to understand its valuation trends.

Anika Therapeutics in the last 5 years

  • Overview

  • Trends

Lowest (-29.01x)

December 31, 2022

Today (-12.64x)

December 31, 2025

Industry (2.29x)

December 31, 2025

Highest (124.82x)

December 31, 2021

LowHigh

Today’s Price to Earnings Ratio: -12.64x

Anika Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Anika Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$281.4M-47%-78.0362.16%0.00%
BUY$21.3B148.54%16.5586.14%0.00%
HOLD$19.1B26.23%-47.5834.83%2.82%
BUY$40.0BNA18.7765.57%1.35%
BUY$30.3B-63.21%12.0170.87%2.86%

Stock Returns calculator for Anika Therapeutics Stock including INR - Dollar returns

The Anika Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Anika Therapeutics investment value today

Current value as on today

₹2,53,884

Returns

₹1,53,884

(+153.88%)

Returns from Anika Therapeutics Stock

₹1,33,820 (+133.82%)

Dollar Impact

₹20,063 (+20.06%)

Analyst Recommendation on Anika Therapeutics Stock

Based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for Anika Therapeutics. Average target price of $21

Anika Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Anika Therapeutics.

What analysts predicted

0.9%UPSIDE

Target Price

$21

Current Price

$20.81

Analyzed by

2 Analysts

Target

$21.00

Anika Therapeutics target price $21, a slight upside of 0.9% compared to current price of $20.81. According to 2 analysts rating.

Indian Investors' Interest in Anika Therapeutics Stock

Search interest for Anika Therapeutics Stock has decreased by -13% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-13% versus previous 30 day period

Anika Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
40
30
38
-1
26
28
27
30
29
32
Gross Profit
24
20
1
22
14
14
15
19
18
21
Operating Income
-5
-1
-28
27
-4
-4
-3
0
-5
2
EBITDA
-1
0
-25
26
-2
-2
0
2
-3
4
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
2
2
2
1
1
1
1
1
1
1
Income Before Tax
-4
-1
-27
28
-3
-3
-2
0
-4
3
Income Tax Expense
0
1
2
2
0
0
0
-1
0
0
Net Income
-4
0
-29
-21
-4
-3
-2
0
-5
3
Net Profit Margin
60.78%
66.69%
3.72%
-1749.22%
56.10%
50.90%
56.02%
62.65%
64.15%
65.15%

Anika Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
113
105
114
130
147
113
120
119
112
Gross Profit
86
74
85
69
82
73
82
75
63
Operating Income
45
21
34
-28
2
3
0
-5
-11
EBITDA
50
27
40
-1
-4
18
17
5
-3
Interest Expense
-
-
-
0
-
-
-
-
-
Depreciation
4
5
5
13
14
14
14
8
5
Income Before Tax
46
23
36
-28
2
4
3
-2
-9
Income Tax Expense
14
4
8
-4
-1
2
6
6
0
Net Income
31
18
27
-23
4
-14
-82
-56
-10
Net Profit Margin
75.87%
70.37%
74.92%
52.91%
56.12%
64.33%
68.33%
63.38%
56.56%

Anika Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-1
0
-29
-21
-4
-3
-2
0
-5
3
Operating Cash Flow
0
-1
5
1
0
0
6
4
-4
0
Investing Cash Flow
-1
-3
-1
-1
1
0
-1
0
-1
-1
Financing Cash Flow
-2
-1
-3
-5
-5
0
0
-5
-10
0
Change in Cash
0
-5
0
-5
-3
0
4
0
-16
-2

Anika Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
31
18
27
-23
4
-14
-82
-56
-10
Operating Cash Flow
40
34
37
13
8
4
-1
5
11
Investing Cash Flow
-12
-50
39
-71
-3
-7
-5
-8
0
Financing Cash Flow
0
-28
-8
-3
-6
-4
-6
-12
-10
Change in Cash
28
-44
68
-61
-1
-8
-13
-15
0

Mutual Funds that own Anika Therapeutics Stock

Check out the Mutual Funds with significant holdings in Anika Therapeutics.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
4.42103%
591665
DFA INVESTMENT DIMENSIONS GROUP INC
1.982632%
265335
Fidelity Concord Street Trust
1.094099%
146423
Fidelity Salem Street Trust
1.037415%
138837
Franklin Value Investors Trust
0.966265%
129315

Global Institutional Holdings in Anika Therapeutics

Funds
Holdings
Vanguard
4.72%
iShares
3.47%
Dimensional
1.2%
Fidelity
0.79%
Schwab
0.56%

Insights on Anika Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -5.05M → 3.30M (in $), with an average increase of 252.8% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, ANIK stock has moved up by 44.3%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, ANIK has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 29.61M → 32.60M (in $), with an average increase of 9.2% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, United Therapeutics Corporation Common Stock has given 71.6% return, outperforming this stock by 54.6%

About Anika Therapeutics

Anika Therapeutics, Inc. is a company dedicated to joint preservation, innovating and providing early intervention orthopedic care across the globe, including the United States and Europe. Their core focus areas include osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and advanced bone-preserving joint technologies. All of Anika's products are developed, manufactured, and commercialized utilizing their proprietary hyaluronic acid (HA) technology platform. Their comprehensive product lines feature an OA pain management family, which includes established treatments like Monovisc, Orthovisc, Cingal, and Hyvisc, all designed to alleviate discomfort from osteoarthritis. The company's joint preservation and restoration offerings are extensive, comprising approximately 150 bone-sparing joint technology products, alongside solutions for sports medicine soft tissue repair and orthopedic regenerative therapies. Furthermore, Anika leverages its HA expertise in a non-orthopedic product family, developing applications such as adhesion barriers, advanced wound care products, ophthalmic solutions, and ear, nose, and throat treatments. Anika Therapeutics, Inc. was established in 1983 and is based in Bedford, Massachusetts.
OrganisationAnika Therapeutics
Headquarters32 Wiggins Avenue, Bedford, MA, 01730, US
IndustryMedical - Specialties
CEOStephen D. Griffin
E-voting on sharesClick here to vote

Key Management of Anika Therapeutics

Name

Title

Dr. Cheryl Renee Blanchard Ph.D.

Executive Chair

Mr. Stephen D. Griffin

President, Principal Financial Officer, CEO & Director

Mr. Ian W. McLeod

Senior VP, Chief Accounting Officer & Treasurer

Mr. Matthew Hall

Executive Director of Corporate Development & Investor Relations

Ms. Lisa Funiciello

VP & Chief Human Resources Officer

Mr. Ben Joseph

Senior Vice President of Commercial

Ms. Mira Leiwant

Senior Vice President of Regulatory, Quality & Clinical Affairs

FAQs

What is Anika Therapeutics share price today?

Anika Therapeutics share price today is $20.81 as on at the close of the market. Anika Therapeutics share today touched a day high of $21.05 and a low of $20.59.

What is the 52 week high and 52 week low for Anika Therapeutics share?

Anika Therapeutics share touched a 52 week high of $22.88 on and a 52 week low of $8.67 on . Anika Therapeutics stock price today i.e. is closed at $20.81,which is 9.05% down from its 52 week high and 139.98% up from its 52 week low.

What is Anika Therapeutics's market capitalisation today?

Anika Therapeutics market capitalisation is $0.00T as on .

How to invest in Anika Therapeutics Stock (ANIK) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Anika Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Anika Therapeutics Shares that will get you 0.0721 shares as per Anika Therapeutics share price of $20.81 per share as on September 19, 2026 at 8:45 am IST.

What is the minimum amount required to buy Anika Therapeutics Stock (ANIK) from India?

Indian investors can start investing in Anika Therapeutics (ANIK) shares with as little as ₹95.88 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.80 in Anika Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Anika Therapeutics share’s latest price of $20.81 as on September 19, 2026 at 8:45 am IST, you will get 0.4805 shares of Anika Therapeutics. Learn more about fractional shares .

What are the returns that Anika Therapeutics has given to Indian investors in the last 5 years?

Anika Therapeutics stock has given -47% share price returns and 30.25% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?